4//SEC Filing
Reine Allan 4
Accession 0001894562-25-000026
CIK 0001894562other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:18 PM ET
Size
5.0 KB
Accession
0001894562-25-000026
Insider Transaction Report
Form 4
Reine Allan
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-05-21$1.18/sh+125,000$147,150→ 125,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.20, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001714023
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:18 PM ET
- Size
- 5.0 KB